| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10592778 | Bioorganic & Medicinal Chemistry Letters | 2014 | 4 Pages |
Abstract
Isoxazoles 27 and 28 were discovered as novel c-jun N-terminal kinase (JNK) inhibitors with good biochemical potency and greatly improved selectivity over p38 as compared to the lead compound 3. Extensive SAR and an efficient route for the formation of bis- and tris-substituted isoxazole groups will be described.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Yuanjun He, Derek Duckett, Weimin Chen, Yuan Yuan Ling, Michael D. Cameron, Li Lin, Claudia H. Ruiz, Philip V. LoGrasso, Theodore M. Kamenecka, Marcel Koenig,